Populations susceptible to B. cepacia infection

B. cepacia poses little medical risk to healthy people. However, people who have certain health problems like weakened immune systems or chronic lung diseases, particularly cystic fibrosis, may be more susceptible to infections with B. cepacia.B cepacia is a known cause of infections in hospitalized patients.

Symptoms of B. cepacia infection

The effects of B. cepacia on people vary widely, ranging from no symptoms at all to serious respiratory infections, especially in patients with cystic fibrosis.

Transmission of B. cepacia infection

Transmission of B. cepacia from contaminated medicines and devices has been reported.
In 2005, CDC was notified by several states of clusters of pneumonia and other infections caused by B. cepacia and associated with contaminated mouthwash.
In 2004, CDC was notified of a voluntary recall of over-the-counter nasal spray due to contamination with B. cepaciacomplex. For more information see the MMWR article.
Also in 2004, B. cepacia was linked to nosocomial infections among intensive care unit patients and associated with exposure to sublingual probes. For more information see theMMWR article.
B. cepacia can also be spread to susceptible persons by:

• Person-to-person contact
• Contact with contaminated surfaces
• Exposure to B. cepacia in the environment.

Treatment of B. cepacia infection

B. cepacia can be resistant to many common antibiotics. Decisions on the treatment of infections with B. cepacia should be made on a case-by-case basis.

Recommendations and Guidelines

Careful attention to infection control procedures like hand hygiene can help reduce the risk of transmission of this organism.